Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

S. Pusceddu, N. Prinzi, G. Lo Russo, D. Femia, M. Milione, F. Perrone, E. Tamborini, L. Concas, I. Pulice, C. Vernieri, F. Corti, R. Buzzoni, F. De Braud

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)1677-1683
Number of pages7
JournalFuture Oncology
Volume13
Issue number19
DOIs
Publication statusPublished - 2017

Cite this